AACR Grant Giving
Investing in Innovation: The AACR grants program sparks innovation in basic, translational, and clinical research by providing critical support to promising investigators at all career levels.
Learn More
Investing in Innovation: The AACR grants program sparks innovation in basic, translational, and clinical research by providing critical support to promising investigators at all career levels.
Learn More
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreScreening for Early Detection: Using evidence-based guidelines to screen for cancer can help find aberrations at the earliest possible detectable phase of cancer development and progression.
Read the ReportMore than 80,000 people in the United States are expected to be diagnosed with non-Hodgkin lymphoma this year. Learn about the treatment options for this type of cancer.
Learn MoreIn the latest episode of Believe in Progress, Mitch talks with award-winning entertainer, author, entrepreneur, and advocate Patti LaBelle. Each episode of this podcast highlights the impact of cancer science.
Listen and SubscribeAACR grantee and NextGen Star Chemtai Mungo, MD, MPH, is developing an innovative self-treatment strategy for cervical precancer that could save lives in underserved areas.
Learn MoreYour donation to the American Association for Cancer Research today will help fund early-career investigators. Gifts from first-time donors will be matched for twice the impact against cancer.
Donate NowEarly registration is now open. Register by Friday, December 15, to receive the lowest rates.
The AACR Cancer Progress Report 2023 provides a comprehensive overview of the latest research-driven advances against the collection of devastating diseases called cancer.
Learn MoreThe AACR and its more than 54,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreA new wave of research-driven discoveries and technological innovations are delivering – and will propel additional – transformative advances to save more lives from cancer..
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2020
Learn Moretherapeutics were approved for new or expanded uses by the FDA from Aug. 1, 2022, to July 31, 2023
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 54,000 members worldwide drive progress against cancer.
Donate Now
